Works by Finn, Richard S

Results: 65

Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.

Published in:

Liver International, 2009, v. 29, n. 2, p. 284, doi. 10.1111/j.1478-3231.2008.01762.x

By:

Finn, Richard S.;
Bentley, Greg;
Britten, Carolyn D.;
Amado, Rafael;
Busuttil, Ronald W.

Publication type:

Article

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.

Published in:

Oncologist, 2022, v. 27, n. 12, p. e938, doi. 10.1093/oncolo/oyac183

By:

Finn, Richard S;
Yau, Thomas;
Hsu, Chih-Hung;
Toni, Enrico N De;
Goyal, Lipika;
Galle, Peter R;
Qin, ShuKui;
Rao, Sujata;
Sun, Fangfang;
Wang, Chunxiao;
Widau, Ryan C;
Zhu, Andrew X

Publication type:

Article

Evaluation of the Association of Polymorphisms With Palbociclib‐Induced Neutropenia: Pharmacogenetic Analysis of PALOMA‐2/‐3.

Published in:

Oncologist, 2021, v. 26, n. 7, p. e1143, doi. 10.1002/onco.13811

By:

Iwata, Hiroji;
Umeyama, Yoshiko;
Liu, Yuan;
Zhang, Zhe;
Schnell, Patrick;
Mori, Yuko;
Fletcher, Olivia;
Marshall, Jean‐Claude;
Johnson, Jillian G.;
Wood, Linda S.;
Toi, Masakazu;
Finn, Richard S.;
Turner, Nicholas C.;
Bartlett, Cynthia Huang;
Cristofanilli, Massimo

Publication type:

Article

Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up

Published in:

Oncologist, 2021, v. 26, n. 5, p. e749, doi. 10.1002/onco.13684

By:

Finn, Richard S.;
Rugo, Hope S.;
Gelmon, Karen A.;
Cristofanilli, Massimo;
Colleoni, Marco;
Loi, Sherene;
Schnell, Patrick;
Lu, Dongrui R.;
Theall, Kathy Puyana;
Mori, Ave;
Gauthier, Eric;
Bananis, Eustratios;
Turner, Nicholas C.;
Diéras, Véronique

Publication type:

Article

Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial.

Published in:

Oncologist, 2019, v. 24, n. 12, p. 1514, doi. 10.1634/theoncologist.2019-0019

By:

Diéras, Véronique;
Harbeck, Nadia;
Joy, Anil Abraham;
Gelmon, Karen;
Ettl, Johannes;
Verma, Sunil;
Lu, Dongrui R.;
Gauthier, Eric;
Schnell, Patrick;
Mori, Ave;
Rugo, Hope S.;
Finn, Richard S.

Publication type:

Article

Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 6, p. 655, doi. 10.1159/000539897

By:

Finn, Richard S.;
Galle, Peter R.;
Ducreux, Michel;
Cheng, Ann-Lii;
Reilly, Norelle;
Nicholas, Alan;
Hernandez, Sairy;
Ma, Ning;
Merle, Philippe;
Salem, Riad;
Li, Daneng;
Breder, Valeriy

Publication type:

Article

Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 537, doi. 10.1159/000537947

By:

Finn, Richard S.;
Qin, Shukui;
Piscaglia, Fabio;
Evans, Thomas R. Jeffry;
Knox, Jennifer J.;
López López, Carlos;
Ramji, Zahra;
Ren, Min;
Mody, Kalgi;
Vogel, Arndt;
Kudo, Masatoshi

Publication type:

Article

Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 548, doi. 10.1159/000537966

By:

Finn, Richard S.;
Kudo, Masatoshi;
Barnes, Gisoo;
Meyer, Tim;
Boisserie, Frederic;
Abdrashitov, Ramil;
Chen, Yaxi;
Li, Songzi;
Zhu, Andrew X.;
Qin, Shukui;
Vogel, Arndt

Publication type:

Article

Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 401, doi. 10.1159/000535501

By:

Kudo, Masatoshi;
Tsuchiya, Kaoru;
Shao, Yu-Yun;
Finn, Richard S.;
Galle, Peter R.;
Ducreux, Michel;
Cheng, Ann-Lii;
Yamashita, Tatsuya;
Koga, Hironori;
Take, Ryosuke;
Yamada, Kyoko;
Asakawa, Takashi;
Nakagawa, Yuki;
Ikeda, Masafumi

Publication type:

Article

A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 451, doi. 10.1159/000535154

By:

Kudo, Masatoshi;
Finn, Richard S.;
Ikeda, Masafumi;
Sung, Max W.;
Baron, Ari D.;
Okusaka, Takuji;
Kobayashi, Masahiro;
Kumada, Hiromitsu;
Kaneko, Shuichi;
Pracht, Marc;
Meyer, Tim;
Nagao, Satoshi;
Saito, Kenichi;
Mody, Kalgi;
Ramji, Zahra;
Dubrovsky, Leonid;
Llovet, Josep M.

Publication type:

Article

Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 479, doi. 10.1159/000529996

By:

Kudo, Masatoshi;
Finn, Richard S.;
Cheng, Ann-Lii;
Zhu, Andrew X.;
Ducreux, Michel;
Galle, Peter R.;
Sakamoto, Naoya;
Kato, Naoya;
Nakano, Michitaka;
Jia, Jing;
Vogel, Arndt

Publication type:

Article

Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 510, doi. 10.1159/000533166

By:

Vogel, Arndt;
Finn, Richard S.;
Blanchet Zumofen, Marie-Hélène;
Heuser, Carolina;
Sanchez Alvarez, Javier;
Leibfried, Michael;
Mitchell, Catherine R.;
Batson, Sarah;
Redhead, Gabrielle;
Gaillard, Vincent E.;
Kudo, Masatoshi

Publication type:

Article

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636

By:

Merle, Philippe;
Kudo, Masatoshi;
Edeline, Julien;
Bouattour, Mohamed;
Cheng, Ann-Lii;
Chan, Stephen Lam;
Yau, Thomas;
Garrido, Marcelo;
Knox, Jennifer;
Daniele, Bruno;
Breder, Valeriy;
Lim, Ho Yeong;
Ogasawara, Sadahisa;
Cattan, Stéphane;
Chao, Yee;
Siegel, Abby B.;
Martinez-Forero, Iván;
Wei, Ziwen;
Liu, Chih-Chin;
Finn, Richard S.

Publication type:

Article

IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 238, doi. 10.1159/000528272

By:

Kudo, Masatoshi;
Finn, Richard S.;
Galle, Peter R.;
Zhu, Andrew X.;
Ducreux, Michel;
Cheng, Ann-Lii;
Ikeda, Masafumi;
Tsuchiya, Kaoru;
Aoki, Ken-ichi;
Jia, Jing;
Lencioni, Riccardo

Publication type:

Article

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 44, doi. 10.1159/000525499

By:

Hsu, Chiun;
Ducreux, Michel;
Zhu, Andrew X.;
Qin, Shukui;
Ikeda, Masafumi;
Kim, Tae-You;
Galle, Peter R.;
Finn, Richard S.;
Chen, Ethan;
Ma, Ning;
Hu, Youyou;
Li, Lindong;
Cheng, Ann-Lii

Publication type:

Article

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605

By:

Kudo, Masatoshi;
Finn, Richard S.;
Morimoto, Manabu;
Rau, Kun-Ming;
Ikeda, Masafumi;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Daniele, Bruno;
Lim, Ho Yeong;
McIlwain, David W.;
Yoshikawa, Reigetsu;
Nakamura, Kenichi;
Liang, Kun;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605

By:

Kudo, Masatoshi;
Finn, Richard S.;
Morimoto, Manabu;
Rau, Kun-Ming;
Ikeda, Masafumi;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Daniele, Bruno;
Lim, Ho Yeong;
McIlwain, David W.;
Yoshikawa, Reigetsu;
Nakamura, Kenichi;
Liang, Kun;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 93, doi. 10.1159/000504624

By:

Alsina, Angel;
Kudo, Masatoshi;
Vogel, Arndt;
Cheng, Ann-Lii;
Tak, Won Young;
Ryoo, Baek-Yeol;
Evans, Thomas R. Jeffry;
López López, Carlos;
Daniele, Bruno;
Misir, Soamnauth;
Ren, Min;
Izumi, Namiki;
Qin, Shukui;
Finn, Richard S.

Publication type:

Article

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928

By:

Vogel, Arndt;
Merle, Philippe;
Verslype, Chris;
Finn, Richard S.;
Zhu, Andrew X.;
Cheng, Ann-Lii;
Chan, Stephen Lam;
Yau, Thomas;
Ryoo, Baek-Yeol;
Knox, Jennifer;
Daniele, Bruno;
Qin, Shukui;
Wei, Ziwen;
Miteva, Yanna;
Malhotra, Usha;
Siegel, Abby B.;
Kudo, Masatoshi

Publication type:

Article

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928

By:

Vogel, Arndt;
Merle, Philippe;
Verslype, Chris;
Finn, Richard S.;
Zhu, Andrew X.;
Cheng, Ann-Lii;
Chan, Stephen Lam;
Yau, Thomas;
Ryoo, Baek-Yeol;
Knox, Jennifer;
Daniele, Bruno;
Qin, Shukui;
Wei, Ziwen;
Miteva, Yanna;
Malhotra, Usha;
Siegel, Abby B.;
Kudo, Masatoshi

Publication type:

Article

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.

Published in:

2021

By:

Zhu, Andrew X.;
Finn, Richard S.;
Kang, Yoon-Koo;
Yen, Chia-Jui;
Galle, Peter R.;
Llovet, Josep M.;
Assenat, Eric;
Brandi, Giovanni;
Motomura, Kenta;
Ohno, Izumi;
Daniele, Bruno;
Vogel, Arndt;
Yamashita, Tatsuya;
Hsu, Chih-Hung;
Gerken, Guido;
Bilbruck, John;
Hsu, Yanzhi;
Liang, Kun;
Widau, Ryan C.;
Wang, Chunxiao

Publication type:

journal article

Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.

Published in:

2019

By:

Evans, Thomas R. Jeffry;
Kudo, Masatoshi;
Finn, Richard S.;
Han, Kwang-Hyub;
Cheng, Ann-Lii;
Ikeda, Masafumi;
Kraljevic, Silvija;
Ren, Min;
Dutcus, Corina E.;
Piscaglia, Fabio;
Sung, Max W.

Publication type:

corrected article

Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.

Published in:

2019

By:

Evans, Thomas R. Jeffry;
Kudo, Masatoshi;
Finn, Richard S.;
Han, Kwang-Hyub;
Cheng, Ann-Lii;
Ikeda, Masafumi;
Kraljevic, Silvija;
Ren, Min;
Dutcus, Corina E.;
Piscaglia, Fabio;
Sung, Max W.

Publication type:

journal article

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.

Published in:

2017

By:

Bendell, Johanna C;
Javle, Milind;
Bekaii-Saab, Tanios S;
Finn, Richard S;
Wainberg, Zev A;
Laheru, Daniel A;
Weekes, Colin D;
Tan, Benjamin R;
Khan, Gazala N;
Zalupski, Mark M;
Infante, Jeffrey R;
Jones, Suzanne;
Papadopoulos, Kyriakos P;
Tolcher, Anthony W;
Chavira, Renae E;
Christy-Bittel, Janna L;
Barrett, Emma;
Patnaik, Amita

Publication type:

journal article

Bilateral Subfoveal Neurosensory Retinal Detachment Associated With MEK Inhibitor Use for Metastatic Cancer.

Published in:

JAMA Ophthalmology, 2014, v. 132, n. 8, p. 1005, doi. 10.1001/jamaophthalmol.2014.976

By:

McCannel, Tara A.;
Chmielowski, Bartosz;
Finn, Richard S.;
Goldman, Jonathan;
Ribas, Antoni;
Wainberg, Zev A.;
McCannel, Colin A.

Publication type:

Article

Lapatinib, a Dual-Targeted Small Molecule Inhibitor of Egfr and Her2, in Her2-Amplified Breast Cancer: From Bench to Bedside.

Published in:

Clinical Medicine Insights: Therapeutics, 2011, n. 3, p. 1, doi. 10.4137/CMT.S3783

By:

Tsang, Roger Y.;
Sadeghi, Saeed;
Finn, Richard S.

Publication type:

Article

Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 69, doi. 10.1007/s11523-020-00771-5

By:

Zheng, Jenny;
Yu, Yanke;
Durairaj, Chandrasekar;
Diéras, Véronique;
Finn, Richard S.;
Wang, Diane D.

Publication type:

Article

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.

Published in:

International Journal of Molecular Sciences, 2013, v. 14, n. 2, p. 3094, doi. 10.3390/ijms14023094

By:

Fejzo, Marlena S.;
Anderson, Lee;
Euw, Erika M. von;
Kalous, Ondrej;
Avliyakulov, Nuraly K.;
Haykinson, Michael J.;
Konecny, Gottfried E.;
Finn, Richard S.;
Slamon, Dennis J.

Publication type:

Article

Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States.

Published in:

Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 231, doi. 10.2147/JHC.S459983

By:

Finn, Richard S;
Iyer, Renuka;
Kalman, Richard S;
Parikh, Neehar D;
Cabrera, Roniel;
Babajanyan, Svetlana;
Kaseb, Ahmed O

Publication type:

Article

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1

By:

Zhu, Zhou;
Turner, Nicholas C.;
Loi, Sherene;
André, Fabrice;
Martin, Miguel;
Diéras, Véronique;
Gelmon, Karen A.;
Harbeck, Nadia;
Zhang, Cathy;
Cao, Joan Q.;
Yan, Zhengming;
Lu, Dongrui R.;
Wei, Ping;
VanArsdale, Todd L.;
Rejto, Paul A.;
Huang, Xin;
Rugo, Hope S.;
Loibl, Sibylle;
Cristofanilli, Massimo;
Finn, Richard S.

Publication type:

Article

Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.

Published in:

NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-0123-0

By:

Court, Colin M.;
Hou, Shuang;
Liu, Lian;
Winograd, Paul;
DiPardo, Benjamin J.;
Liu, Sean X.;
Chen, Pin-Jung;
Zhu, Yazhen;
Smalley, Matthew;
Zhang, Ryan;
Sadeghi, Saeed;
Finn, Richard S.;
Kaldas, Fady M.;
Busuttil, Ronald W.;
Zhou, Xianghong J.;
Tseng, Hsian-Rong;
Tomlinson, James S.;
Graeber, Thomas G.;
Agopian, Vatche G.

Publication type:

Article

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer.

Published in:

NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00479-x

By:

Rugo, Hope S.;
Brufsky, Adam;
Liu, Xianchen;
Li, Benjamin;
McRoy, Lynn;
Chen, Connie;
Layman, Rachel M.;
Cristofanilli, Massimo;
Torres, Mylin A.;
Curigliano, Giuseppe;
Finn, Richard S.;
DeMichele, Angela

Publication type:

Article

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.

Published in:

Oncogene, 1997, v. 15, n. 5, p. 537, doi. 10.1038/sj.onc.1201222

By:

Pegram, Mark D;
Finn, Richard S;
Arzoo, Karo;
Beryt, Malgorzata;
Pietras, Richard J;
Slamon, Dennis J

Publication type:

Article

New Horizons in the Treatment and Management of Hepatocellular Carcinoma: Expert Perspectives on the Evolving Role of Immunotherapy.

Published in:

Journal of Managed Care Medicine, 2021, v. 24, n. 4, p. 31

By:

Finn, Richard S.

Publication type:

Article

Noninvasive prognostication of hepatocellular carcinoma based on cell-free DNA methylation.

Published in:

PLoS ONE, 2025, v. 20, n. 4, p. 1, doi. 10.1371/journal.pone.0321736

By:

Hu, Ran;
Tran, Benjamin;
Li, Shuo;
Stackpole, Mary L.;
Zeng, Weihua;
Zhou, Yonggang;
Melehy, Andrew;
Sadeghi, Saeed;
Finn, Richard S.;
Zhou, Xianghong Jasmine;
Li, Wenyuan;
Agopian, Vatche G.

Publication type:

Article

Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240.

Published in:

Cancer (0008543X), 2021, v. 127, n. 6, p. 865, doi. 10.1002/cncr.33317

By:

Ryoo, Baek‐Yeol;
Merle, Philippe;
Kulkarni, Amit S.;
Cheng, Ann‐Lii;
Bouattour, Mohamed;
Lim, Ho Yeong;
Breder, Valeriy;
Edeline, Julien;
Chao, Yee;
Ogasawara, Sadahisa;
Yau, Thomas;
Garrido, Marcelo;
Chan, Stephen L.;
Daniele, Bruno;
Norquist, Josephine M.;
Chen, Erluo;
Siegel, Abby B.;
Zhu, Andrew X.;
Finn, Richard S.;
Kudo, Masatoshi

Publication type:

Article

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

Published in:

Liver International, 2021, v. 41, n. 11, p. 2759, doi. 10.1111/liv.14994

By:

Galle, Peter R.;
Kudo, Masatoshi;
Llovet, Josep M.;
Finn, Richard S.;
Karwal, Mark;
Pezet, Denis;
Kim, Tae‐You;
Yang, Tsai‐Sheng;
Lonardi, Sara;
Tomasek, Jiri;
Phelip, Jean‐Marc;
Touchefeu, Yann;
Koh, Su‐Jin;
Stirnimann, Guido;
Liang, Kun;
Ogburn, Kenyon D.;
Wang, Chunxiao;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.

Published in:

Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462

By:

Kudo, Masatoshi;
Galle, Peter R.;
Llovet, Josep M.;
Finn, Richard S.;
Vogel, Arndt;
Motomura, Kenta;
Assenat, Eric;
Merle, Philippe;
Brandi, Giovanni;
Daniele, Bruno;
Okusaka, Takuji;
Tomášek, Jiří;
Borg, Christophe;
Dadduzio, Vincenzo;
Morimoto, Manabu;
Pracht, Marc;
Jen, Min‐Hua;
Drove Ubreva, Nora;
Widau, Ryan C.;
Shinozaki, Kenta

Publication type:

Article

Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites.

Published in:

Hepatology Research, 2021, v. 51, n. 6, p. 715, doi. 10.1111/hepr.13638

By:

Kudo, Masatoshi;
Ikeda, Masafumi;
Galle, Peter R.;
Yamashita, Tatsuya;
Finn, Richard S.;
Liang, Kun;
Wang, Chunxiao;
Sakaguchi, Sachi;
Abada, Paolo;
Widau, Ryan C.;
Zhu, Andrew X.

Publication type:

Article

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

Published in:

Oncogene, 1999, v. 18, n. 44, p. 6050, doi. 10.1038/sj.onc.1202993

By:

Aguilar, Zuleima;
Akita, Robert W;
Finn, Richard S;
Ramos, B Lillian;
Pegram, Mark D;
Kabbinavar, Fairooz F;
Pietras, Richard J;
Pisacane, Paul;
Sliwkowski, Mark X;
Slamon, Dennis J

Publication type:

Article

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Published in:

Oncogene, 1998, v. 17, n. 17, p. 2235, doi. 10.1038/sj.onc.1202132

By:

Pietras, Richard J;
Pegram, Mark D;
Finn, Richard S;
Maneval, Daniel A;
Slamon, Dennis J

Publication type:

Article

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2− Metastatic Breast Cancer.

Published in:

Cancers, 2023, v. 15, n. 18, p. 4558, doi. 10.3390/cancers15184558

By:

Zhao, Joseph J.;
Fong, Khi Yung;
Chan, Yiong Huak;
Tey, Jeremy;
Dawood, Shaheenah;
Lee, Soo Chin;
Finn, Richard S.;
Sundar, Raghav;
Lim, Joline S. J.

Publication type:

Article

Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.

Published in:

2016

By:

Finn, Richard S.;
Aleshin, Alexey;
Slamon, Dennis J.

Publication type:

journal article

Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.

Published in:

CardioVascular & Interventional Radiology, 2022, v. 45, n. 4, p. 405, doi. 10.1007/s00270-021-03031-9

By:

Llovet, Josep M.;
Vogel, Arndt;
Madoff, David C.;
Finn, Richard S.;
Ogasawara, Sadahisa;
Ren, Zhenggang;
Mody, Kalgi;
Li, Jerry J.;
Siegel, Abby B.;
Dubrovsky, Leonid;
Kudo, Masatoshi

Publication type:

Article

Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.

Published in:

NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00658-y

By:

Cheang, Maggie Chon U.;
Rimawi, Mothaffar;
Johnston, Stephen;
Jacobs, Samuel A.;
Bliss, Judith;
Pogue-Geile, Katherine;
Kilburn, Lucy;
Zhu, Zhou;
Schuster, Eugene F.;
Xiao, Hui;
Swaim, Lisa;
Deng, Shibing;
Lu, Dongrui R.;
Gauthier, Eric;
Tursi, Jennifer;
Slamon, Dennis J.;
Rugo, Hope S.;
Finn, Richard S.;
Liu, Yuan

Publication type:

Article

Covalent Chemistry‐Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.

Published in:

Advanced Materials Technologies, 2021, v. 6, n. 5, p. 1, doi. 10.1002/admt.202001056

By:

Sun, Na;
Lee, Yi‐Te;
Kim, Minhyung;
Wang, Jasmine J.;
Zhang, Ceng;
Teng, Pai‐Chi;
Qi, Dongping;
Zhang, Ryan Y.;
Tran, Benjamin V.;
Lee, Yue Tung;
Ye, Jinglei;
Palomique, Juvelyn;
Nissen, Nicholas N.;
Han, Steven‐Huy B.;
Sadeghi, Saeed;
Finn, Richard S.;
Saab, Sammy;
Busuttil, Ronald W.;
Posadas, Edwin M.;
Liang, Li

Publication type:

Article

Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab.

Published in:

PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056112

By:

Ather, Ferdows;
Hamidi, Habib;
Fejzo, Marlena S.;
Letrent, Stephen;
Finn, Richard S.;
Kabbinavar, Fairooz;
Head, Christian;
Wong, Steven G.

Publication type:

Article

Developing a Treatment Plan for Hepatocellular Carcinoma: The Continuum of Care.

Published in:

Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 9

By:

Finn, Richard S.

Publication type:

Article

The Role of Liver Biopsy in Hepatocellular Carcinoma.

Published in:

Clinical Advances in Hematology & Oncology, 2016, v. 14, n. 10, p. 759

By:

Finn, Richard S.

Publication type:

Article

Extending Survival With the Use of Targeted Therapy in the Treatment of Hepatocellular Carcinoma.

Published in:

Clinical Advances in Hematology & Oncology, 2013, v. 11, p. 1

By:

Gish, Robert G.;
Finn, Richard S.;
Marrero, Jorge A.

Publication type:

Article